As Lentiviral vectors have transformed medicine with their safety and efficacy, they have created a demand for production that far exceeds current capacity.

Traditional manufacturing systems have seen long wait times and critical raw material shortages cause delays in development and deployment of these life-altering therapies.

Our Intelligent Vector Solutions(TM) can be used to manufacture ANY LENTI, ANY SCALE(TM) to provide our clients an END TO END solution, speeding their development and securing their supply chain.

Biotechnology

iVexSol

Rodney L. Rietze

Maroof Alam

Cameron Hamilton

Lauren Revene

Andrew Lussier

Andrey Grigoryev

Kaytrina Anchelia

Amha Mulaw

Matthew Gay

Mary Schier

Heather Puksta

Vikram Sarveiya

The Scientific Research Team at iVexSol is dedicated to advancing the development and manufacturing of lentiviral vectors. They conduct cutting-edge research to optimize viral vector production processes, ensuring scalability and efficiency. By leveraging their expertise, the team supports the innovation of Intelligent Vector Solutions(TM) that meet the high demands of the biopharmaceutical industry, ultimately accelerating the delivery of life-changing therapies.

Scientific Research Team

Scientific Research Team

About

Team members